nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Meta-proteogenomic Approach to Peptide Identification Incorporating Assembly Uncertainty and Genomic Variation*
|
Li, Sujun |
|
|
|
8S1 |
p. S183-S192 |
artikel |
2 |
An Integrative Analysis of Tumor Proteomic and Phosphoproteomic Profiles to Examine the Relationships Between Kinase Activity and Phosphorylation*
|
Arshad, Osama A. |
|
|
|
8S1 |
p. S26-S36 |
artikel |
3 |
Author Index
|
|
|
|
|
8S1 |
p. v |
artikel |
4 |
Author Index
|
|
|
|
|
8S1 |
p. S389-S412 |
artikel |
5 |
Author Index
|
|
|
|
|
8S1 |
p. S68-S70 |
artikel |
6 |
Calendar
|
|
|
|
|
8S1 |
p. S413-S414 |
artikel |
7 |
Calendar
|
|
|
|
|
8S1 |
p. S71-S72 |
artikel |
8 |
Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer*
|
Zhan, Xiaohui |
|
|
|
8S1 |
p. S37-S51 |
artikel |
9 |
Editorial Board
|
|
|
|
|
8S1 |
p. i-ii |
artikel |
10 |
Editorial Board
|
|
|
|
|
8S1 |
p. i-ii |
artikel |
11 |
Editorial Board
|
|
|
|
|
8S1 |
p. i-ii |
artikel |
12 |
Editorial Board
|
|
|
|
|
8S1 |
p. i-ii |
artikel |
13 |
Editorial Board
|
|
|
|
|
8S1 |
p. i-ii |
artikel |
14 |
Editorial Board
|
|
|
|
|
8S1 |
p. i-ii |
artikel |
15 |
Exploiting Interdata Relationships in Next-generation Proteomics Analysis*
|
Vitrinel, Burcu |
|
|
|
8S1 |
p. S5-S14 |
artikel |
16 |
Extracting Pathway-level Signatures from Proteogenomic Data in Breast Cancer Using Independent Component Analysis*
|
Liu, Wenke |
|
|
|
8S1 |
p. S169-S182 |
artikel |
17 |
Graph Algorithms for Condensing and Consolidating Gene Set Analysis Results*
|
Savage, Sara R. |
|
|
|
8S1 |
p. S141-S152 |
artikel |
18 |
Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics*
|
Federspiel, Joel D. |
|
|
|
8S1 |
p. S92-S113 |
artikel |
19 |
Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis*
|
Song, Xiaoyu |
|
|
|
8S1 |
p. S52-S65 |
artikel |
20 |
Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors*
|
Ma, Weiping |
|
|
|
8S1 |
p. S66-S81 |
artikel |
21 |
Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications*
|
Brademan, Dain R. |
|
|
|
8S1 |
p. S193-S201 |
artikel |
22 |
metaQuantome: An Integrated, Quantitative Metaproteomics Approach Reveals Connections Between Taxonomy and Protein Function in Complex Microbiomes*
|
Easterly, Caleb W. |
|
|
|
8S1 |
p. S82-S91 |
artikel |
23 |
Mini Symposium
|
|
|
|
|
8S1 |
p. S11-S13 |
artikel |
24 |
Mini Symposium
|
|
|
|
|
8S1 |
p. S14-S17 |
artikel |
25 |
Mini Symposium
|
|
|
|
|
8S1 |
p. S13-S16 |
artikel |
26 |
MOGSA: Integrative Single Sample Gene-set Analysis of Multiple Omics Data*
|
Meng, Chen |
|
|
|
8S1 |
p. S153-S168 |
artikel |
27 |
Multi-omics Characterization of Interaction-mediated Control of Human Protein Abundance levels*
|
Sousa, Abel |
|
|
|
8S1 |
p. S114-S125 |
artikel |
28 |
Poster Session A
|
|
|
|
|
8S1 |
p. S18-S25 |
artikel |
29 |
Poster Session A
|
|
|
|
|
8S1 |
p. S21-S33 |
artikel |
30 |
Poster Session A
|
|
|
|
|
8S1 |
p. S21-S38 |
artikel |
31 |
Poster Session A
|
|
|
|
|
8S1 |
p. S19-S27 |
artikel |
32 |
Poster Session B
|
|
|
|
|
8S1 |
p. S31-S39 |
artikel |
33 |
Poster Session B
|
|
|
|
|
8S1 |
p. S38-S50 |
artikel |
34 |
Poster Session B
|
|
|
|
|
8S1 |
p. S43-S60 |
artikel |
35 |
Poster Session B
|
|
|
|
|
8S1 |
p. S33-S40 |
artikel |
36 |
Poster Session C
|
|
|
|
|
8S1 |
p. S44-S52 |
artikel |
37 |
Poster Session C
|
|
|
|
|
8S1 |
p. S53-S64 |
artikel |
38 |
Poster Session C
|
|
|
|
|
8S1 |
p. S44-S52 |
artikel |
39 |
Program
|
|
|
|
|
8S1 |
p. S1-S10 |
artikel |
40 |
Program
|
|
|
|
|
8S1 |
p. S1-S10 |
artikel |
41 |
Program
|
|
|
|
|
8S1 |
p. S1-S11 |
artikel |
42 |
PROTEOFORMER 2.0: Further Developments in the Ribosome Profiling-assisted Proteogenomic Hunt for New Proteoforms*
|
Verbruggen, Steven |
|
|
|
8S1 |
p. S126-S140 |
artikel |
43 |
Proteomics Is Not an Island: Multi-omics Integration Is the Key to Understanding Biological Systems*
|
Zhang, Bing |
|
|
|
8S1 |
p. S1-S4 |
artikel |
44 |
Reproducibility and Transparency by Design*
|
Petyuk, Vladislav A. |
|
|
|
8S1 |
p. S202-S204 |
artikel |
45 |
Revised Draft Guidelines for Proteomic Data Publication
|
|
|
|
|
8S1 |
p. ix-xi |
artikel |
46 |
Session 4
|
|
|
|
|
8S1 |
p. S29-S30 |
artikel |
47 |
Session 5
|
|
|
|
|
8S1 |
p. S40-S41 |
artikel |
48 |
Session 2
|
|
|
|
|
8S1 |
p. S16-S17 |
artikel |
49 |
Session 1
|
|
|
|
|
8S1 |
p. S14-S15 |
artikel |
50 |
Session 6
|
|
|
|
|
8S1 |
p. S42-S43 |
artikel |
51 |
Session 8
|
|
|
|
|
8S1 |
p. S55-S56 |
artikel |
52 |
Session 3
|
|
|
|
|
8S1 |
p. S26-S28 |
artikel |
53 |
Session 7
|
|
|
|
|
8S1 |
p. S53-S54 |
artikel |
54 |
Session 2
|
|
|
|
|
8S1 |
p. S20 |
artikel |
55 |
Session 4
|
|
|
|
|
8S1 |
p. S37 |
artikel |
56 |
Session 7
|
|
|
|
|
8S1 |
p. S65-S66 |
artikel |
57 |
Session 8
|
|
|
|
|
8S1 |
p. S67 |
artikel |
58 |
Session 1
|
|
|
|
|
8S1 |
p. S18-S19 |
artikel |
59 |
Session 6
|
|
|
|
|
8S1 |
p. S52 |
artikel |
60 |
Session 3
|
|
|
|
|
8S1 |
p. S34-S36 |
artikel |
61 |
Session 5
|
|
|
|
|
8S1 |
p. S51 |
artikel |
62 |
Session 2
|
|
|
|
|
8S1 |
p. S39-S42 |
artikel |
63 |
Session 1
|
|
|
|
|
8S1 |
p. S17-S20 |
artikel |
64 |
Session 3
|
|
|
|
|
8S1 |
p. S41-S43 |
artikel |
65 |
Session 1
|
|
|
|
|
8S1 |
p. S11-S18 |
artikel |
66 |
Session 2
|
|
|
|
|
8S1 |
p. S28-S32 |
artikel |
67 |
Session 4
|
|
|
|
|
8S1 |
p. S65-S68 |
artikel |
68 |
Session 3
|
|
|
|
|
8S1 |
p. S61-S64 |
artikel |
69 |
Session 4
|
|
|
|
|
8S1 |
p. S53-S56 |
artikel |
70 |
Session 2: Bioinformatics
|
|
|
|
|
8S1 |
p. S17-S34 |
artikel |
71 |
Session 3: Functional Proteomics-Cell Signaling
|
|
|
|
|
8S1 |
p. S35-S43 |
artikel |
72 |
Session 4: Functional Proteomics-Protein-Protein Interactions and Networks
|
|
|
|
|
8S1 |
p. S44-S59 |
artikel |
73 |
Session 5: HUPO Initiatives-Antibodies
|
|
|
|
|
8S1 |
p. S60-S67 |
artikel |
74 |
Session 6: HUPO Initiatives-Brain
|
|
|
|
|
8S1 |
p. S68-S73 |
artikel |
75 |
Session 7: HUPO Initiatives-Glycoproteomics
|
|
|
|
|
8S1 |
p. S74-S76 |
artikel |
76 |
Session 8: HUPO Initiatives-Liver
|
|
|
|
|
8S1 |
p. S77-S80 |
artikel |
77 |
Session 9: HUPO Initiatives-New Technologies
|
|
|
|
|
8S1 |
p. S81-S84 |
artikel |
78 |
Session 10: HUPO Initiatives-Plasma
|
|
|
|
|
8S1 |
p. S85-S87 |
artikel |
79 |
Session 11: HUPO Initiatives-Standards
|
|
|
|
|
8S1 |
p. S88 |
artikel |
80 |
Session 41: Industry Sponsored Symposia
|
|
|
|
|
8S1 |
p. S387-S388 |
artikel |
81 |
Session 1: Invited Speaker Abstracts
|
|
|
|
|
8S1 |
p. S1-S16 |
artikel |
82 |
Session 13: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Cancer Proteomics
|
|
|
|
|
8S1 |
p. S98-S139 |
artikel |
83 |
Session 14: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Clinical Biomarker Discovery
|
|
|
|
|
8S1 |
p. S140-S169 |
artikel |
84 |
Session 15: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Heart & Stroke
|
|
|
|
|
8S1 |
p. S170-S176 |
artikel |
85 |
Session 16: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Liver
|
|
|
|
|
8S1 |
p. S177-S182 |
artikel |
86 |
Session 17: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Neuroproteomics
|
|
|
|
|
8S1 |
p. S183-S196 |
artikel |
87 |
Session 18: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Obesity & Diabetes
|
|
|
|
|
8S1 |
p. S197-S200 |
artikel |
88 |
Session 23: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Other
|
|
|
|
|
8S1 |
p. S226-S232 |
artikel |
89 |
Session 19: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Other Tissues
|
|
|
|
|
8S1 |
p. S201-S209 |
artikel |
90 |
Session 20: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Plasma
|
|
|
|
|
8S1 |
p. S210-S215 |
artikel |
91 |
Session 21: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Target Identification and Validation
|
|
|
|
|
8S1 |
p. S216-S219 |
artikel |
92 |
Session 22: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Toxicology
|
|
|
|
|
8S1 |
p. S220-S225 |
artikel |
93 |
Session 24: Model Organisms-Microbial Proteomes
|
|
|
|
|
8S1 |
p. S233-S251 |
artikel |
94 |
Session 25: Model Organisms-Other Non-Mammalian Proteomes
|
|
|
|
|
8S1 |
p. S252-S255 |
artikel |
95 |
Session 26: Model Organisms-Plant Proteomes
|
|
|
|
|
8S1 |
p. S256-S261 |
artikel |
96 |
Session 39: News Corner
|
|
|
|
|
8S1 |
p. S360-S382 |
artikel |
97 |
Session 12: Organellar Proteomics
|
|
|
|
|
8S1 |
p. S89-S97 |
artikel |
98 |
Session 40: Other
|
|
|
|
|
8S1 |
p. S383-S386 |
artikel |
99 |
Session 27: Post-Translational Modifications-Glycosylation and Glycoproteomics
|
|
|
|
|
8S1 |
p. S262-S267 |
artikel |
100 |
Session 28: Post-Translational Modifications-Other Post-Translational Modifications
|
|
|
|
|
8S1 |
p. S268-S272 |
artikel |
101 |
Session 29: Post-Translational Modifications-Phosphorylation and Phosphoproteomics
|
|
|
|
|
8S1 |
p. S273-S284 |
artikel |
102 |
Session 30: Proteomics in Biotechnology
|
|
|
|
|
8S1 |
p. S285-S289 |
artikel |
103 |
Session 31: Proteomics Technologies-2D Electrophoresis
|
|
|
|
|
8S1 |
p. S290-S298 |
artikel |
104 |
Session 33: Proteomics Technologies-Mass Spectrometry-based Quantitative Proteomics
|
|
|
|
|
8S1 |
p. S314-S329 |
artikel |
105 |
Session 32: Proteomics Technologies-Mass Spectrometry Technology
|
|
|
|
|
8S1 |
p. S299-S313 |
artikel |
106 |
Session 34: Proteomics Technologies-Nanotechnology/Protein Arrays
|
|
|
|
|
8S1 |
p. S330-S338 |
artikel |
107 |
Session 37: Proteomics Technologies-Other
|
|
|
|
|
8S1 |
p. S351-S357 |
artikel |
108 |
Session 36: Proteomics Technologies-Protein Chemistry
|
|
|
|
|
8S1 |
p. S348-S350 |
artikel |
109 |
Session 35: Proteomics Technologies-Protein Prefractionation Technologies
|
|
|
|
|
8S1 |
p. S339-S347 |
artikel |
110 |
Session 38: Structural Proteomics
|
|
|
|
|
8S1 |
p. S358-S359 |
artikel |
111 |
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data*
|
Chen, Mei-Ju May |
|
|
|
8S1 |
p. S15-S25 |
artikel |